The Humanised Liver Mice Model Market involves the creation of genetically engineered mice with human-like liver functions. These models improve drug testing, disease research, and toxicity studies, allowing pharmaceutical and biotech companies to accelerate preclinical research with better insights into human liver responses.
According to FutureWise analysis, the Humanised Liver Mice Model Market in 2026 is US$141.7 million and is expected to reach US$293.16 million by 2036 at a CAGR of 7.54%. Market growth is driven by rising demand for reliable preclinical models in drug metabolism, hepatotoxicity studies, and research on infectious diseases such as hepatitis and liver fibrosis. Humanised liver mice provide better translational relevance than traditional models, accelerating drug discovery and reducing clinical trial failures.
Growth Drivers:
- Rising demand for accurate preclinical drug testing and toxicity studies.
- Increasing prevalence of liver diseases and need for effective therapies.
- Growth in biopharmaceutical and personalised medicine research.
- Technological advancements in genetic engineering and humanised models.
- Regulatory push for safer and more predictive animal models.
Key Trends:
- Advancements in genetic engineering for precise models.
- Rising demand for predictive preclinical testing.
- Growth in personalised medicine and toxicology research.
- Expansion in the Asia-Pacific and North America markets.
- Collaborations among biotech firms and research institutes.
Market Segmentation and Key Players:
The Humanized Liver Mice Model Market is segmented by application (such as pharmacokinetics studies, in-vivo liver toxicity testing, and drug metabolism studies), model type (including uPA-SCID, FRG KO mice, and TK-NOG mice), end users (like pharmaceutical companies, biotechnology companies, CROs, and academic/research institutes), and regions (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa). Comprehensive segmentation details are provided in the Segmentation section below.
Major companies operating in the Humanised Liver Mice Model Market include The Jackson Laboratory, Charles River Laboratories International, Inc., and Taconic Biosciences, Inc., among others.
Research Methodology:
The Humanised Liver Mice Model Market research conducted by FutureWise Research employs a combination of primary interviews with industry stakeholders and secondary sources, such as reports and journals. This approach integrates quantitative market sizing and forecasting with qualitative insights into trends, competition, and strategies to deliver a comprehensive overview of the market.